- Home
- THAR vs JZXN Comparison
THAR vs JZXN Comparison
Compare THAR & JZXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THAR
- JZXN
- Stock Information
- Founded
- THAR 2017
- JZXN 2019
- Country
- THAR United States
- JZXN China
- Employees
- THAR N/A
- JZXN N/A
- Industry
- THAR Biotechnology: Pharmaceutical Preparations
- JZXN Retail-Auto Dealers and Gas Stations
- Sector
- THAR Health Care
- JZXN Consumer Discretionary
- Exchange
- THAR Nasdaq
- JZXN Nasdaq
- Market Cap
- THAR 22.8M
- JZXN 21.8M
- IPO Year
- THAR 2022
- JZXN 2021
- Fundamental
- Price
- THAR $3.62
- JZXN $0.27
- Analyst Decision
- THAR Strong Buy
- JZXN
- Analyst Count
- THAR 1
- JZXN 0
- Target Price
- THAR $17.00
- JZXN N/A
- AVG Volume (30 Days)
- THAR 2.6M
- JZXN 10.2M
- Earning Date
- THAR 11-07-2025
- JZXN 03-05-2026
- Dividend Yield
- THAR N/A
- JZXN N/A
- EPS Growth
- THAR N/A
- JZXN N/A
- EPS
- THAR N/A
- JZXN N/A
- Revenue
- THAR N/A
- JZXN $97,465.00
- Revenue This Year
- THAR N/A
- JZXN N/A
- Revenue Next Year
- THAR N/A
- JZXN N/A
- P/E Ratio
- THAR N/A
- JZXN N/A
- Revenue Growth
- THAR N/A
- JZXN N/A
- 52 Week Low
- THAR $0.95
- JZXN $0.25
- 52 Week High
- THAR $9.08
- JZXN $7.82
- Technical
- Relative Strength Index (RSI)
- THAR 56.35
- JZXN 34.10
- Support Level
- THAR $2.85
- JZXN $0.26
- Resistance Level
- THAR $6.89
- JZXN $0.39
- Average True Range (ATR)
- THAR 0.49
- JZXN 0.04
- MACD
- THAR 0.04
- JZXN 0.02
- Stochastic Oscillator
- THAR 14.85
- JZXN 6.47
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
About JZXN Jiuzi Holdings Inc.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its operating segments are propretaey product; and resale of sourced Equipment and accessories from third party products. The company generates a majority of its revenue from the propretaey product segment. Geographically, the firm operates in China.